We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTMI icon
1276
TTM Technologies
TTMI
$14.5B
$3K ﹤0.01%
323
-24,177
-99% -$259K
STX icon
1277
Seagate
STX
$184B
$2K ﹤0.01%
+28
New +$1.37K
DPZ icon
1278
Domino's
DPZ
$11.6B
$1K ﹤0.01%
3
-4,192
-100% -$1.04M
MKC icon
1279
McCormick & Company Non-Voting
MKC
$14.2B
$1K ﹤0.01%
+16
New +$1.29K
SLRC icon
1280
SLR Investment Corp
SLRC
$715M
$1K ﹤0.01%
+58
New +$1.19K
CAI
1281
DELISTED
CAI International, Inc.
CAI
$1K ﹤0.01%
+67
New +$1.48K
AA icon
1282
Alcoa
AA
$13.2B
-50,688
Closed -$1.19M
AAP icon
1283
Advance Auto Parts
AAP
$3.49B
-3,989
Closed -$615K
AB icon
1284
AllianceBernstein
AB
$3.47B
-61,254
Closed -$1.82M
ABG icon
1285
Asbury Automotive
ABG
$3.85B
-7,820
Closed -$660K
ABT icon
1286
Abbott
ABT
$187B
-1,884,363
Closed -$158M
ADMA icon
1287
ADMA Biologics
ADMA
$2.22B
-291,538
Closed -$1.13M
ADSK icon
1288
Autodesk
ADSK
$52.6B
-20,752
Closed -$3.38M
AEG icon
1289
Aegon
AEG
$14.1B
-326,228
Closed -$1.43M
AGNC icon
1290
AGNC Investment
AGNC
$12.9B
-367,250
Closed -$6.18M
AIZ icon
1291
Assurant
AIZ
$14.3B
-28,253
Closed -$3.01M
AKRO
1292
DELISTED
Akero Therapeutics
AKRO
-54,304
Closed -$1.04M
ALE
1293
DELISTED
Allete
ALE
-7,331
Closed -$610K
ALLO icon
1294
Allogene Therapeutics
ALLO
$694M
-9,531
Closed -$256K
ALNY icon
1295
Alnylam Pharmaceuticals
ALNY
$29.3B
-181,395
Closed -$13.2M
ALSN icon
1296
Allison Transmission
ALSN
$9.82B
-46,916
Closed -$2.17M
AMN icon
1297
AMN Healthcare
AMN
$1.4B
-15,429
Closed -$837K
AMP icon
1298
Ameriprise Financial
AMP
$48.8B
-106,614
Closed -$15.5M
ANF icon
1299
Abercrombie & Fitch
ANF
$5B
-73,867
Closed -$1.19M
AOS icon
1300
A.O. Smith
AOS
$8.7B
-17,817
Closed -$841K

Similar funds

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.